Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Regeneron Pharmaceuticals, Inc. (REGN) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Regeneron Pharmaceuticals, Inc. (REGN) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for September 11th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 11th:
CarMax Inc. (KMX - Free Report) : This retailer of used vehicles has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 0.3% over the last 60 days.
CarMax Inc Price and Consensus
CarMax Inc Price and Consensus | CarMax Inc Quote
CarMax’s shares gained 7.1% over the last one month more than S&P 500’s gain of 1%. The company possesses a Momentum Score of A.
CarMax Inc Price
CarMax Inc Price | CarMax Inc Quote
Catabasis Pharmaceuticals, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.5% over the last 60 days.
Catabasis Pharmaceuticals, Inc. Price and Consensus
Catabasis Pharmaceuticals, Inc. Price and Consensus | Catabasis Pharmaceuticals, Inc. Quote
Catabasis Pharmaceuticals’ shares gained 19.1% over the last one month. The company possesses a Momentum Score of A.
Catabasis Pharmaceuticals, Inc. Price
Catabasis Pharmaceuticals, Inc. Price | Catabasis Pharmaceuticals, Inc. Quote
Ross Stores, Inc. (ROST - Free Report) : This apparel company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.2% over the last 60 days.
Ross Stores, Inc. Price and Consensus
Ross Stores, Inc. Price and Consensus | Ross Stores, Inc. Quote
Ross Stores’ shares gained 6.8% over the last one month. The company possesses a Momentum Score of A.
Ross Stores, Inc. Price
Ross Stores, Inc. Price | Ross Stores, Inc. Quote
Regeneron Pharmaceuticals, Inc. (REGN - Free Report) : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.8% over the last 60 days.
Regeneron Pharmaceuticals, Inc. Price and Consensus
Regeneron Pharmaceuticals, Inc. Price and Consensus | Regeneron Pharmaceuticals, Inc. Quote
Regeneron Pharmaceuticals’ shares gained 2.5% over the last one month. The company possesses a Momentum Score of A.
Regeneron Pharmaceuticals, Inc. Price
Regeneron Pharmaceuticals, Inc. Price | Regeneron Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
4 Surprising Tech Stocks to Keep an Eye On
Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really take off.
See Stocks Now>>